Two large health insurers are hoping a new "public utility" patient data sharing service will improve one of the most pernicious problems in American healthcare.
Two large health insurers are hoping a new "public utility" patient data sharing service will improve one of the most pernicious problems in American healthcare.
Blue Shield of California and WellPoint, the parent of Anthem Blue Cross, are investing a combined $80 million to start the California Integrated Data Exchange, as a “next generation” health information exchange service for providers, payers and patients.
Dubbed Cal INDEX, the service will offer California physicians, nurses and hospitals “a unified statewide source of integrated patient information.” It will be one of the largest exchanges in the country, starting off with the health records of a quarter of the state population, the companies say.
Read the full story: http://bit.ly/1u4L7da
Source: Healthcare Payer News
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More